Colossal Facet Immunology conference invites you with regards to the aim on Research…Innovation…science and encompassing scientific facet, which also strives to raise awareness which explore the current global issues to understand how current Scenario affects research approach to face challenges. The conference is going to be held at Madrid, Spain from May 03-05, 2017. `The theme of the conference is on "Prevalent concepts and precision techniques in the arena of immunology and infectious diseases".The main aim is to create a dialogue of diverse characteristics in both fields and to explore advances in health practice, management and education in relation to disparities as well as a breadth of other topics. Colossal conferences will consider interdisciplinary and transdisciplinary themes that address the challenges in various fields from multiple theoretical and practical standpoints. Our goal is to provide an inspiring and enthusiastic dialogue for constructive and critical communication.
Immune-mediated inflammatory diseases are a very common set of chronic disorders that affect 5–7% of western populations. The market is expected to experience continued growth, from $61.5 billion in 2015 to $74.2 billion in 2022, at a compound annual growth rate of 2.71%.The immunology treatment market's Compound Annual Growth Rate (CAGR) will equal a relatively stable 2.71%, due to practical and regulatory barriers to entry for biosimilars that are not present for small molecule generics, and a moderately strong late-stage pipeline.PB-501, a biosimilar of Humira, which was the best-selling drug of 2014 worldwide, is anticipated to generate annual revenues of almost $1 billion by 2022, making it an exceptionally strong-performing non-patented drug.The infectious immunology market is segmented based on types of diseases into HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. Approximately 4,00,000 deaths are estimated to be caused by rotavirus infection. HBV affected nearly 1.4 million in the U.S. in past years. Quantitative analysis of the current market and estimations through 2013-2020 are provided to showcase the financial calibre of the infectious immunology market.
The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019. Traditional diagnostic techniques such as immunodiagnostics and biochemical characterization are the largest segments of the IDD market. However, molecular diagnostic techniques, such as microarrays and isothermal nucleic acid amplification technology (INAAT), will show the fastest growth in the forecast period.The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012. Market growth looks promising, the overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2016. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market. Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 009 77o $6.2 billion in 2017. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2017.
Colossal Facet conferences provides a scientific platform and opportunity for delegates from various universities and associations across the globe to share their research, practice, and educational initiatives and to interpret and critically evaluate concepts and ideas expressed in a variety of forms and how to apply the knowledge, skills and methodologies.
Please submit your abstracts on any of the listed sessions below.
Melia Barajas, Avda. de Logroño 305, 28042, Madrid, Spain